Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Larry Ellberger currently holds 73,500 shares of Celldex Therapeutics, Inc. (CLDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Larry Ellberger has been a net seller of CLDX stock. They have purchased $375.1K and sold $434.3K worth of shares.
Larry Ellberger's most recent insider trade was on Jun 15, 2017, when they sold 10,000 shares at $0.00 per share.
Larry Ellberger serves as Executive at Celldex Therapeutics, Inc. (CLDX). They have executed 24 insider transactions totaling $809.4K over their tenure at the company.
Larry Ellberger holds the position of Executive at Celldex Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Larry Ellberger has shown a selling trading pattern, with $375.1K in total purchases and $434.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Larry Ellberger was on Dec 6, 2013, when they sold $434.3K worth of CLDX shares. This transaction involved 17,728 shares at $24.50 per share.
Larry Ellberger currently owns 73,500 shares of Celldex Therapeutics, Inc. (CLDX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Larry Ellberger's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Larry Ellberger has 24 Form 4 filings on record as an insider at Celldex Therapeutics, Inc..
Set alerts for Larry Ellberger and 40,000+ other insiders.